|
|
|
| Short-term Efficacy and Long-term Prognosis of Patients with Diffuse Proximal Advanced Gastric Cancer Treated with Different Surgical Methods |
| JIANG Qiang |
| Ganzi People's Hospital. Sichuan Province, 626000 |
|
|
|
|
Abstract 【Objective】To investigate the short-term efficacy and long-term prognosis of different surgical methods for treating diffuse proximal advanced gastric cancer (AGC).【Methods】A total of 80 patients with diffuse proximal AGC treated in our hospital from February 2011 to April 2014 were enrolled in the study. They were randomly divided into two groups by random number table method, with 40 cases in each group. The observation group (A group) was treated with total gastrectomy, while the control group (B group) was treated with proximal gastrectomy (partial resection). All patients were followed up for 3 years after surgery. The general data, early recovery after surgery, hemoglobin (Hb), albumin (Alb), total protein (TP), 3-year survival rates, tumor-free survival rates and recurrence rates were compared between the two groups.【Results】The surgical time was shorter and intraoperative blood loss was less in the A group compared to those of the B group (P<0.05), while the number of dissected lymph nodes was significantly more than that in the B group (P<0.05). Levels of plasma Hb, Alb and TP one year after surgery in both groups were decreased (P<0.05), but there was no significant difference between the two groups (P>0.05). The 3-year survival rate (53.33%) and tumor-free survival rate (46.67%) of the A group were higher than those of the B group (31.11% and 22.22%, respectively;P<0.05), while there was no significant difference in recurrence rate between the two groups (P>0.05). The incidence of complications in the A group within 3 years after surgery was significantly lower than that in the B group (P<0.05).【Conclusion】The short-term efficacy of total gastrectomy is a good way to treat diffuse proximal AGC. It can shorten the surgical time, reduce intraoperative blood loss, increase the number of dissected lymph nodes, and significantly improve the 3-year survival rate and tumor-free survival rate of patients.
|
|
Received: 23 June 2017
|
|
|
|
|
|
[1] 王晰程,沈琳.遗传性弥漫型胃癌研究现状[J].中华胃肠外科杂志,2015,18(3):295-297.
[2] Edge SB,Compton CC.The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6):1471-1474.
[3] 王盼,杨秀春,刘小宇,等.腹腔镜胃癌根治术治疗进展期胃癌对患者血清应激炎症因子的影响[J].医学临床研究,2016,33(9):1798-1800.
[4] 宋华勇,张帆,马磊,等.术前新辅助化疗对进展期胃癌手术清除率及并发症的影响[J].医学临床研究,2016,33(10):1943-1945.
[5] 王祥峰,杨日高,吴国庆,等.进展期胃癌术中实施区域性缓释化疗的安全性和远期疗效[J].西部医学,2015,27(3):423-425.
[6] 季福建,房学东,姜俊男,等.全胃系膜切除术在进展期胃癌治疗中的应用研究[J].中华胃肠外科杂志,2016,19(10):1097-1100.
[7] 梁勇,徐溢新,宋虎,等.全胃系膜切除与标准D2根治术治疗进展期胃癌的临床对照研究[J].现代消化及介入诊疗,2016,21(6):875-877.
[8] 欧阳杰,李洪,陈思远,等.两种不同手术方式在近端胃癌根治术中的应用[J].国际肿瘤学杂志,2015,42(6):422-425. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2018, 35(5): 1007-1009. |
|
|
|
|
2018, Vol. 35 
